Abstract: The odor exploration method explores an odor based on odor information generated using a plurality of sensor elements each outputting a detection signal according to the state of adsorption by indicating an adsorption reaction unique to each odor substance, and an arithmetic unit generating the odor information by quantifying each detection signal from the sensor elements. The method includes a detection step detecting a first gas containing odor substances, a generation step generating a first odor information group generated based on a detection result of the first gas, a preparation step preparing a second odor information group generated based on a detection of a second gas, and a calculation step calculating a sum of or a difference between the second odor information group and the first odor information group based on a sum of or difference between the odor information generated for the first gas and for the second gas using the same sensor element.

Abstract: A data structure includes a main data storage area in which main data is stored, and an odor data storage area in which odor data is stored. The odor data is based on a measurement result of an odor in air measured by an odor sensor. The odor data storage area stores a plurality of pieces of the odor data. The main data storage area includes a main data ID area for storing a main data ID indicating that the stored data is the main data. The odor data storage area includes an odor data ID area for storing an odor data ID indicating that the stored data is the odor data.

Abstract: To provide an odor sensor capable of using an additive that was not capable of being adopted in an odor sensor including a polymer film, an odor measurement system using the odor sensor, and a method for producing the odor sensor, an odor sensor comprises a plurality of sensor elements, the sensor element including a substance absorption film adsorbing an odor substance; and a detection unit detecting adsorption of the odor substance with respect to the substance absorption film, wherein the substance absorption film is a porous fine particle film that contains fine particles containing a compound having silicon and oxygen as a skeleton, and a surface modifier for modifying surfaces of the fine particles, and in at least a part of the plurality of sensor elements, compositions of the fine particles and/or the surface modifier are different from each other.

Abstract: The present invention provides a nucleic acid molecule dimer that includes a first nucleic acid molecule having complementarity with at least part of a target nucleic acid molecule, and a second nucleic acid molecule having complementarity with the first nucleic acid molecule, wherein the first nucleic acid molecule has a linear form, the second nucleic acid molecule has a cyclic form, and the first and second nucleic acid molecules at least partially form a double strand.

Abstract: Compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.

Abstract: The odor exploration method explores an odor based on odor information generated using a plurality of sensor elements each outputting a detection signal according to the state of adsorption by indicating an adsorption reaction unique to each odor substance, and an arithmetic unit generating the odor information by quantifying each detection signal from the sensor elements. The method includes a detection step detecting a first gas containing odor substances, a generation step generating a first odor information group generated based on a detection result of the first gas, a preparation step preparing a second odor information group generated based on a detection of a second gas, and a calculation step calculating a sum of or a difference between the second odor information group and the first odor information group based on a sum of or difference between the odor information generated for the first gas and for the second gas using the same sensor element.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.

Abstract: The present invention provides a nucleic acid molecule dimer that includes a first nucleic acid molecule having complementarity with at least part of a target nucleic acid molecule, and a second nucleic acid molecule having complementarity with the first nucleic acid molecule, wherein the first nucleic acid molecule has a linear form, the second nucleic acid molecule has a cyclic form, and the first and second nucleic acid molecules at least partially form a double strand.

Abstract: A data structure includes a main data storage area in which main data is stored, and an odor data storage area in which odor data is stored. The odor data is based on a measurement result of an odor in air measured by an odor sensor. The odor data storage area stores a plurality of pieces of the odor data. The main data storage area includes a main data ID area for storing a main data ID indicating that the stored data is the main data. The odor data storage area includes an odor data ID area for storing an odor data ID indicating that the stored data is the odor data.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. A nucleic acid molecule can have a) a polynucleotide sense strand and a polynucleotide antisense strand; b) each strand of the molecule being from 15 to 30 nucleotides in length; c) a contiguous region of from 15 to 30 nucleotides of the antisense strand being complementary to a sequence of an mRNA encoding GST-?; and d) at least a portion of the sense strand can be complementary to at least a portion of the antisense strand, and the molecule has a duplex region of from 15 to 30 nucleotides in length.

Abstract: Provided are: a targeting molecule targeting a target cell which is selected from the group consisting of a stellate cell, a myofibroblast, a cancer-associated fibroblast, a tumor cell and a cell expressing STRA6, said targeting molecule being selected from the group consisting of (1) a peptide containing an amino acid sequence in the cell-binding region of RBP, (2) a variant peptide of the aforesaid peptide (1), said variant peptide having a comparable targetability to peptide (1), and (3) a peptide mimetic having a comparable targetability to peptide (1) or peptide (2); a targeting agent, a carrier, a complex and a medicinal composition each comprising the targeting molecule; a method for treating, examining, diagnosing or monitoring a disease related to the aforesaid target cell; a method for labeling, detecting or imaging the target cell, etc.

Abstract: Provided are: a targeting molecule targeting a target cell which is selected from the group consisting of a stellate cell, a myofibroblast, a cancer-associated fibroblast, a tumor cell and a cell expressing STRA6, said targeting molecule being selected from the group consisting of (1) a peptide containing an amino acid sequence in the cell-binding region of RBP, (2) a variant peptide of the aforesaid peptide (1), said variant peptide having a comparable targetability to peptide (1), and (3) a peptide mimetic having a comparable targetability to peptide (1) or peptide (2); a targeting agent, a carrier, a complex and a medicinal composition each comprising the targeting molecule; a method for treating, examining, diagnosing or monitoring a disease related to the aforesaid target cell; a method for labeling, detecting or imaging the target cell, etc.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. A nucleic acid molecule can have a) a polynucleotide sense strand and a polynucleotide antisense strand; b) each strand of the molecule being from 15 to 30 nucleotides in length; c) a contiguous region of from 15 to 30 nucleotides of the antisense strand being complementary to a sequence of an mRNA encoding GST-?; and d) at least a portion of the sense strand can be complementary to at least a portion of the antisense strand, and the molecule has a duplex region of from 15 to 30 nucleotides in length.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.

Abstract: This invention provides compounds, compositions and methods for modulating the expression of human GST-? using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. Provided are a range of siRNA structures, having one or more of nucleotides being modified or chemically-modified. Advantageous structures include siRNAs with 2?-deoxy nucleotides located in the seed region, as well as other nucleotide modifications.